NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

CogDiss Corollaries to the Feuerstein-Ratain Rule

Our happy little stock is showing signs of life, prior to possible TLD. This got me reflecting on the FR-Rule and led to these thoughts:

Corollary 1:
The FR-Rule requires that the trial in question have a generally accepted concept of a date on which the results might be announced.

If no one has an idea when the trial might end, might as well hang the “Gone Fishing” sign.

Corollary 2:
Conversely, if the market cap of the company to be reporting data rises above $300 million, the odds of success increase infinitely.

This is due to the mathematical result of dividing any non-zero number by zero.

To infinity and beyond!

BTW, I predicted TLD in mid-September, within the four month timeframe of the FR-Rule. Always the optimist.


For your entertainment:

Celator jumps 400% in after market trading, shatters FR-Rule:

http://www.redacre.com/insights/140316191/biotech-shatters-rule-jumps-400


Jazz Pharmaceuticals acquires Celator for $1.5 billion

https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-and-celator-pharmaceuticals-announce-agreement-for-jazz-pharmaceuticals-to-acquire-celator-for-3025-per-share-300276751.html